Translational Feasibility of Curcumin for Treatment of Alzheimer’s Disease: A Critical Appraisal of Clinical Challenges

– published in Antioxidants

Summary

Turmeric’s Clinical Evidence Gap

Millions of dollars are poured into researching curcumin for Alzheimer’s, yet clinical trials consistently fall short. While turmeric’s golden bioactive compound boasts powerful antioxidant properties in lab settings, it struggles to cross into the human brain. This critical appraisal cuts through the hype, addressing the stark evidence gap between laboratory success and clinical reality while investigating if advanced nanotechnology can bridge the divide.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *